Product
AI AGENTS
AI APPLICATIONS
OTHERS
Solutions
INDUSTRIES
USE CASES
Pricing
Resources
EXPLORE
ENGAGE
SUPPORT & SERVICES
About
PatSnap Eureka Platform
Agents for IP
Agents for Engineering
Agents for Life Sciences
Agents for Materials
Analytics
IP IntelligenceSynapse
Biopharma IntelligenceBio
Biosequence Search and AnalysisChemical
Chemical Structure Search and AnalysisOpen Platform
NEWProfessional Services
Law Firms
Life Sciences
High-Tech
Competitor Tech Research
Design Risk Screening
Customer Stories
Newsroom
Blog
Global Innovation Report
Glossary
Webinars & Training
Frontier
User Community
Trust and Security
PatentBench
NEWLLM
Help center
Careers
Access to over 2,000,000,000 structured data points around patents, science, litigation, and tech sectors
Innovate 75% faster at 25% less cost
Cloud or on-prem for maximum privacy and control
Trusted by more than 18,000 innovators worldwide
To use , click the vertification button in the email we sent to [email protected].
This helps keep your account secure.
You should receive it shortly. Don’t forget to check your spam folder.
Unlock professional features and history
Already have an account? Log In
To start using PatSnap Eureka, click the verification button in the email we sent to .
This helps keep your account secure.
Haven't received it? Check your spam folder.
Thoughtfully curated series offering valuable insights for innovation professionals
Article | Report How STING agonists, RIG-I activators, ENPP1 inhibitors, and advanced delivery platforms are reprogramming the tumor microenvironment in solid tumors.
Article | Report Enzymes, engineered microbes, and hybrid electro-biological systems are rewriting the carbon capture playbook. Explore the 2026 biocatalytic CO₂ technology landscape.
Article | Report How substrate noise coupling degrades RF performance in bulk CMOS versus SOI technology for 5G transceivers—mechanisms, circuit impacts, and patented mitigation strategies.
Article | Report Enzymes, engineered microbes, and hybrid electro-biological systems are reshaping CO₂ capture. Explore the 2026 biocatalytic carbon capture technology landscape.
Article | Report Explore the NK cell therapy pipeline across hematologic and solid tumors — CAR-NK, iPSC-derived, CIML, and NK engager strategies shaping immuno-oncology in 2025.
Article | Report How directed self-assembly (DSA) complements EUV lithography for sub-30 nm contact hole patterning at 3–5 nm nodes. Key materials, process strategies, and IP landscape.
Article | Report How CAR-NK, allogeneic, and iPSC-derived NK cell therapies are reshaping immuno-oncology — covering AML, solid tumors, and the evolving target landscape.
Article | Report How DSA complements EUV lithography for sub-30 nm contact hole patterning: block copolymers, neutral layers, DSA-OPC, and density multiplication at 3–5 nm nodes.
Article | Report Microplasma technology is reshaping biomedical, environmental, and semiconductor sectors. Explore the 2026 patent and innovation landscape with PatSnap.
Article | Report How do static and dynamic DRAM refresh strategies differ for automotive-grade LPDDR5? Analysis of 45+ patents covering power, reliability, and ISO 26262 compliance.
Article | Report How do static and dynamic DRAM refresh strategies differ for automotive-grade LPDDR5? Analysis of 45+ patents covering temperature-compensation, PASR, ECC, and ADAS reliability.
Article | Report Zinc ion batteries are emerging as a post-lithium storage platform. Explore the 2026 technology landscape: cathode materials, anode stabilization, electrolyte IP, and grid-scale applications.
Article | Report Trispecific antibodies targeting CD38, BCMA, and CD3 are emerging as the next frontier in multiple myeloma therapy. Explore the patent pipeline, key players, and clinical signals.
Article | Report Up to 99% of NIDS alerts are false positives. Discover proven AI techniques—hybrid ML, alert correlation, GNNs, and XAI—to cut false positive rates in OT networks.
Article | Report Up to 99% of NIDS alerts are false positives. Discover proven AI and ML techniques to reduce false positive rates in OT network intrusion detection systems.